| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adenocarcinoma | D000230 | 166 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Mammary Neoplasms, Experimental | D008325 | 67 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Precancerous Conditions | D011230 | 48 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
2E,6E-farnesol
2e,6e-farnesol is a lipid of Prenol Lipids (PR) class. 2e,6e-farnesol is associated with abnormalities such as Granulomatous Disease, Chronic, pathologic fistula and Cavitation. The involved functions are known as Regulation, Metabolic Inhibition, cholesterol biosynthetic process, Process and Transcription, Genetic. 2e,6e-farnesol often locates in Plasma membrane, Cytoplasmic matrix, cornified envelope, Epidermis and peroxisome. The associated genes with 2E,6E-farnesol are RAB3A gene, FOSL1 gene, CASP8AP2 gene, RCC1 gene and GALE gene. The related lipids are Sterols, Membrane Lipids and Steroids.
Cross Reference
Introduction
To understand associated biological information of 2E,6E-farnesol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 2E,6E-farnesol?
2E,6E-farnesol is suspected in Granulomatous Disease, Chronic, pathologic fistula and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2E,6E-farnesol
PubChem Associated disorders and diseases
What pathways are associated with 2E,6E-farnesol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 2E,6E-farnesol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 2E,6E-farnesol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 2E,6E-farnesol?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 2E,6E-farnesol?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 2E,6E-farnesol?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 2E,6E-farnesol
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kato K et al. | Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. | 1992 | Proc. Natl. Acad. Sci. U.S.A. | pmid:1631135 |
| Jackson JH et al. | Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. | 1990 | Proc. Natl. Acad. Sci. U.S.A. | pmid:2183224 |
| Caldwell GA et al. | Consequences of altered isoprenylation targets on a-factor export and bioactivity. | 1994 | Proc. Natl. Acad. Sci. U.S.A. | pmid:8108401 |
| Laezza C et al. | v-K-ras leads to preferential farnesylation of p21(ras) in FRTL-5 cells: multiple interference with the isoprenoid pathway. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9811854 |
| Lu Y et al. | Quorum sensing controls hyphal initiation in Candida albicans through Ubr1-mediated protein degradation. | 2014 | Proc. Natl. Acad. Sci. U.S.A. | pmid:24449897 |
| Stone KJ and Strominger JL | Inhibition of sterol biosynthesis by bacitracin. | 1972 | Proc. Natl. Acad. Sci. U.S.A. | pmid:4338587 |
| Thai L et al. | Farnesol is utilized for isoprenoid biosynthesis in plant cells via farnesyl pyrophosphate formed by successive monophosphorylation reactions. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:10557276 |
| Jansen B et al. | Novel Ras antagonist blocks human melanoma growth. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:10570191 |
| Law JH et al. | Synthesis of a material with high juvenile hormone activity. | 1966 | Proc. Natl. Acad. Sci. U.S.A. | pmid:5221241 |
| Cornforth J | Symmetry of squalene epoxidation in vivo. | 1977 | Proc. R. Soc. Lond., B, Biol. Sci. | pmid:22855 |
| Donninger C and Popják G | Studies on the biosynthesis of cholesterol. 18. The stereospecificity of mevaldate reductase and the biosynthesis of asymmetrically labelled farnesyl pyrophosphate. | 1966 | Proc. R. Soc. Lond., B, Biol. Sci. | pmid:4379290 |
| McPherson RA et al. | The novel Ras antagonist, farnesylthiosalicylate, suppresses growth of prostate cancer in vitro. | 2004 | Prostate | pmid:14968433 |
| Banfi C et al. | Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme. | 2009 | Proteomics | pmid:19253276 |
| Blum R et al. | Inhibitors of chronically active ras: potential for treatment of human malignancies. | 2008 | Recent Pat Anticancer Drug Discov | pmid:18289122 |
| Jahangir T et al. | Alleviation of free radical mediated oxidative and genotoxic effects of cadmium by farnesol in Swiss albino mice. | 2005 | Redox Rep. | pmid:16438802 |
| Lima JP et al. | [Gefarnate (DA-688) in the treatment of peptic ulcer; immediate results]. | 1966 | Rev Bras Med | pmid:5940586 |
| Mincis M | [Clinical study of the effect of geranyl of farnesylacetate combined with nafiver in peptic ulcer patients]. | 1968 | Rev Bras Med | pmid:5724217 |
| Pastor Franco A | [Clinicobiological evolution of duodenal ulcer treated with gefarnate]. | 1966 | Rev Clin Esp | pmid:4286000 |
| Marcos Becerro JF and Rodriguez Gorostiza FJ | [The effect of farnesyl geranyl acetate on duodenal ulcer]. | 1968 | Rev Esp Enferm Apar Dig | pmid:5670667 |
| Akisue G | [Secretion of Myroxylon peruiforum L.f. 3. Physical and chemical characterization of essential oil from balsam and qualitative analysis of various componets]. | 1972 Jul-Dec | Rev Farm Bioquim Univ Sao Paulo | pmid:4664898 |
| Styczyńska B and Krzemińska A | [Laboratory testing of control of the Monomorium pharaonis L. ants with the use of juvenile hormones]. | 1981 | Rocz Panstw Zakl Hig | pmid:7313455 |
| Styczyńska B et al. | [Biological activity of the Polish juvenile hormone cyclopren tested on various Diptera species]. | 1980 | Rocz Panstw Zakl Hig | pmid:7466235 |
| Krzemińska A et al. | [Field studies on the effectiveness of insecticides containing juvenile hormones against the ant Monomorium pharaonis L]. | 1983 | Rocz Panstw Zakl Hig | pmid:6612185 |
| Styczyńska B and Sereda B | [Effect of hormone-like substances on the gonads of domestic fly (Musca domestica L.)]. | 1979 | Rocz Panstw Zakl Hig | pmid:515638 |
| Styczyńska B et al. | [Assessment of the activity of insect hormone analogues. I. Derivatives of 2,3-methylenefarnesol and 2,3-methylenefarnesenic acid]. | 1974 | Rocz Panstw Zakl Hig | pmid:4842239 |
| Crick DC et al. | Geranylgeraniol restores cell proliferation to lovastatin treated C6 glial cells. | 1996 | SAAS Bull. Biochem. Biotechnol. | pmid:8652130 |
| Ilayaraja R et al. | Evaluating the binding efficiency of pheromone binding protein with its natural ligand using molecular docking and fluorescence analysis. | 2014 | Sci Rep | pmid:24903953 |
| Graebe JE | Isoprenoid biosynthesis in a cell-free system from pea shoots. | 1967 | Science | pmid:4381746 |
| Pei ZM et al. | Role of farnesyltransferase in ABA regulation of guard cell anion channels and plant water loss. | 1998 | Science | pmid:9765153 |
| Fukui S | [Sexual differentiation in heterobasidiomycetous yeasts (author's transl)]. | 1980 | Seikagaku | pmid:7019358 |
| Yasugi E | [Induction of apoptosis by isoprenoids]. | 1999 | Seikagaku | pmid:10659677 |
| Zhang X et al. | Nanomicellar carriers for targeted delivery of anticancer agents. | 2014 | Ther Deliv | pmid:24341817 |
| Binet L et al. | [Farnesol, psychosedative and spasmolytic drug]. | 1972 Sep-Oct | Therapie | pmid:4405589 |
| Mussoni L et al. | Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells. | 2000 | Thromb. Haemost. | pmid:10928471 |
| Saito K et al. | An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre/pro-haptens. | 2017 | Toxicol In Vitro | pmid:27965148 |
| Flint OP et al. | Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro. | 1997 | Toxicol. Appl. Pharmacol. | pmid:9221828 |
| Lemaire B et al. | Cytochrome P450 20A1 in zebrafish: Cloning, regulation and potential involvement in hyperactivity disorders. | 2016 | Toxicol. Appl. Pharmacol. | pmid:26853319 |
| Yang SP and Raner GM | Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract. | 2005 | Toxicol. Appl. Pharmacol. | pmid:15629189 |
| Winn LM and Wells PG | Evidence for Ras-dependent signal transduction in phenytoin teratogenicity. | 2002 | Toxicol. Appl. Pharmacol. | pmid:12460742 |
| Schleimer K et al. | Competition between native liver and graft in auxiliary liver transplantation in a rat model. | 2008 | Transplant. Proc. | pmid:18555091 |
| Teodoro JS et al. | Hepatic FXR: key regulator of whole-body energy metabolism. | 2011 | Trends Endocrinol. Metab. | pmid:21862343 |
| Iazlovitskaia EM et al. | Human leukemia CEM C-1 cells possess a high affinity binding site for farnesol. | 1997 Mar-Apr | Ukr. Biokhim. Zh. | pmid:9463231 |
| Cordeiro Rde A et al. | Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes. | 2012 | Vet. Microbiol. | pmid:22580194 |
| Nowak M and Kurnatowski P | [Biofilm caused by fungi--structure, quorum sensing, morphogenetic changes, resistance to drugs]. | 2009 | Wiad Parazytol | pmid:19579780 |
| Styczyńska B et al. | [2,3-methylenefarnesenic acid derivatives as juvenile hormone analogs against housefly (Musca domestica L.)]. | 1977 | Wiad Parazytol | pmid:899003 |
| Weber K et al. | The quorum-sensing molecule E,E-farnesol--its variable secretion and its impact on the growth and metabolism of Candida species. | 2010 | Yeast | pmid:20641010 |
| Uppuluri P et al. | Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue. | 2007 | Yeast | pmid:17583896 |
| Saidi S et al. | In vitro synergistic effect of farnesol and human gingival cells against Candida albicans. | 2006 | Yeast | pmid:16845684 |
| Hintze-Podufal C | The juvenile hormone-like effect of farnesol derivatives on the pupal development of Cerura vinula L. | 1971 | Z. Naturforsch. B | pmid:4396584 |
| Metzler M et al. | On the biosynthesis of juvenile hormone in the adult Cecropia moth. | 1971 | Z. Naturforsch. B | pmid:4401880 |